India  

Mexico experts recommend approving Indian vaccine

IndiaTimes Saturday, 6 March 2021
A technical committee of experts in Mexico gave a unanimous favorable opinion Friday on approving the Covaxin vaccine made by the Indian pharmaceutical company Bharat Biotech. The report by the committee for new molecules will be sent to the federal medical safety commission's approval board, which usually follows such recommendations.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Use entire national capacity to step up Covid vaccine production, PM tells officials

The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
IndiaTimes

India to increase Covaxin production to 100 million doses per month by September

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
IndiaTimes
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."

Credit: ANI    Duration: 01:14Published

Even as Covid vaccine demand rises, firms may take some weeks to up production

Indications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and..
IndiaTimes

BBV152 BBV152 Vaccine against COVID-19

Covaxin production to be increased to 100 million doses per month by September 2021: Centre

Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
DNA

Related news from verified sources

Covishield or Covaxin: Mutant strains in some West Bengal patients raise concerns over vaccine efficacy

The detection of double mutant Covid strain in some Bengal patients has left experts and those waiting to get vaccinated worried about the efficacy of...
IndiaTimes

Covaxin out of clinical trial mode, granted restricted emergency use authorisation

The Centre on Thursday said Bharat Biotech's indigenously developed Covaxin is out of the "clinical trial mode" and that it has now been granted the regular...
IndiaTimes

'Powerful example for all Indians': Bharat Biotech after PM Modi takes Covaxin shot

Prime Minister Narendra Modi on Monday (March 1) was administered the first dose of COVID-19 vaccine, Covaxin at the AIIMS, Delhi.
DNA